About the Journal

The Journal of Experimental Biology and Pharmaceutical Sciences is a peer-reviewed scientific journal that publishes original research in the fields of biology and pharmaceutical sciences. The journal covers a wide range of topics, including:

  • Experimental biology: Biochemistry, biophysics, cell biology, developmental biology, genetics, microbiology, molecular biology, physiology, Ecology, etc
  • Plant Physiology, Plant Biochemistry, Phytochemistry, Pharmacognosy, Agricultural Biotechnology, Plant-Microbe Interactions.
  • Pharmaceutical sciences: Drug discovery, drug development, pharmacology, pharmaceutics, and toxicology, Pharmaceutical Formulation and Delivery, Natural Products, Herbal Medicines,  Pharmaceutical Chemistry, Drug Delivery Systems, Regulatory Affairs, Drug Approval Processes, Pharmaceutical Analysis, etc. 
  • Biopharmaceuticals and Biotechnology: Biopharmaceuticals, Biotechnology, Gene therapy, recombinant DNA technology, and cell-based therapies, Pharmacogenomics.
  • Pharmaceutical Chemistry and Analysis: Medicinal Chemistry, Analytical Chemistry, Regulatory Affairs, Quality Assurance.
  • Toxicology and Safety Assessments: Preclinical Toxicology, Environmental Toxicology
  • Pharmacoeconomics and Health Outcomes: Pharmacoeconomics, Health Outcomes, Health Economics
  • Interdisciplinary and Translational Research: Systems Biology, Bioinformatics, Translational Medicine

The journal aims to provide a platform for researchers to disseminate their findings and contribute to the advancement of knowledge in these fields. Manuscripts are subject to rigorous peer review by experts in the field before acceptance for publication. The journal is committed to maintaining high standards of quality and scientific rigor.

Key features of the Journal of Experimental Biology and Pharmaceutical Sciences:

  • Peer-reviewed: All submissions undergo a thorough review process by experts in the field.
  • Wide scope: Covers a broad range of topics in biology and pharmaceutical sciences.
  • High quality: Maintains high standards of scientific rigor and quality.
  • Open access: Articles are freely available online to all readers.

Target audience:

  • Researchers in biology and pharmaceutical sciences
  • Scientists, academics, and professionals in related fields
  • Students and educators
  • Healthcare providers
  • Government agencies and pharmaceutical companies
  • Policymakers and funding organizations